A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.

Completed · Phase 1

Conditions studied: Rheumatoid Arthritis, Healthy Volunteers

In brief

The study will try, in 2 separate parts, each using 12 research subjects, to see how a new form of the pill CE 224,535 gets released into the bloodstream and whether that is affected by food. In each part, subjects will switch among 4 treatment periods to take either different forms of the pill(s) or the same form either after fasting or eating a meal. The second part will only happen depending on whether the sponsor believes it is needed and will use separate subject than the first part.

Key facts

Study ID

NCT00838058

Run by

Pfizer

People needed

11

Starts

2009-01-01

Expected to finish

2009-03-01

Last updated by the study team

2009-10-14

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• aged 18-55 and healthy

You may not qualify if…

• severe chronic or uncontrolled medical or psychiatric conditions, including drug abuse
• pregnant or wanting to become pregnant

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.